Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | KLK7 | P49862 | 5/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TTR | P02766 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.40 |
| ▸ | UGT1A9 | O60656 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10952749 | 0.87 | ALDH1A1 (0.50) | TSHRHTTTDP1KLK7P2RX7 | |
| SCHEMBL28770289 | 0.84 | TSHR (0.45) | TSHRHTTTDP1KLK7CRHBP | |
| SCHEMBL8644037 | 0.82 | TSHR (0.40) | TSHRHTTTDP1KLK7P2RX7 | |
| SCHEMBL8642449 | 0.81 | TSHR (0.39) | TSHRHTTTDP1KLK7P2RX7 | |
| SCHEMBL10615027 | 0.80 | CLCN2 (0.39) | TSHRHTTTDP1KLK7P2RX7 | |
| SCHEMBL8646856 | 0.79 | PTGS1 (0.41) | TSHRHTTTDP1KLK7P2RX7 | |
| SCHEMBL8370092 | 0.78 | CXCL8 (0.42) | HTTALDH1A1LMNATTRKMT2A | |
| SCHEMBL8646827 | 0.78 | KLK7 (0.38) | TSHRHTTTDP1KLK7CRHBP | |
| SCHEMBL8645157 | 0.78 | TSHR (0.36) | TSHRHTTTDP1KLK7P2RX7 | |
| SCHEMBL8646191 | 0.78 | TSHR (0.36) | TSHRHTTTDP1KLK7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0767777-B1 | NEW SALTS OF 2-[(2,6-DICHLOROPHENYL)AMINE]PHENYLACETOXYACETIC ACID WITH ORGANIC BASIC CATIONS | NOVARTIS AG (CH) | 1999-04-14 | — | — | EP | claimed |
| US-5708024-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | NOVARTIS CORPORATION (US) | 1998-01-13 | — | — | US | claimed |
| US-4548952-A | ANTINFLAMMATORY, ANALGESIC AGENTS | PRODES, S.A. (ES) | 1985-10-22 | — | — | US | claimed |
| JP-63063647-A | — | — | None | — | — | JP | disclosed |
| CN-110143891-B | Preparation method of aceclofenac | 浙江工业大学 | 2022-06-21 | — | — | CN | disclosed |
| CN-112250589-A | Aceclofenac synthesis refining process | 陕西恒诚制药有限公司 | 2021-01-22 | — | — | CN | disclosed |
| EP-2583674-B1 | ACECLOFENAC SLOW-RELEASE PREPARATION PROVIDING AN OPTIMUM PHARMACOLOGICAL CLINICAL EFFECT WHEN ADMINISTERED ONCE A DAY | KOREA UNITED PHARM INC (KR) | 2015-11-18 | — | — | EP | disclosed |
| EP-2583674-A2 | ACECLOFENAC SLOW-RELEASE PREPARATION PROVIDING AN OPTIMUM PHARMACOLOGICAL CLINICAL EFFECT WHEN ADMINISTERED ONCE A DAY | Korea United Pharm, Inc. (KR) | 2013-04-24 | — | — | EP | disclosed |
| EP-2393486-A1 | ACECLOFENAC-CONTAINING CONTROLLED-RELEASE ORAL DRUG PREPARATIONS AND THEIR MANUFACTURING PROCESS | Korea United Pharm, Inc. (KR) | 2011-12-14 | — | — | EP | disclosed |
| WO-2010090371-A1 | ACECLOFENAC-CONTAINING CONTROLLED-RELEASE ORAL DRUG PREPARATIONS AND THEIR MANUFACTURING PROCESS | KOREA UNITED PHARM, INC (KR) | 2010-08-12 | — | — | WO | disclosed |
| EP-1814517-B1 | NONAQUEOUS LIQUID PARENTERAL ACECLOFENAC FORMULATION | VENUS REMEDIES LTD (IN) | 2010-08-11 | — | — | EP | disclosed |
| EP-0738706-B1 | Nitric esters of 2-(2,6-dihalophenylamino) phenylacetoxyacetic acid derivatives and their preparation process | PRODES SA (ES) | 1998-10-07 | — | — | EP | disclosed |
| US-5708024-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | NOVARTIS CORPORATION (US) | 1998-01-13 | — | — | US | disclosed |
| US-5708024-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | NOVARTIS CORPORATION (US) | 1998-01-13 | — | — | US | disclosed |
| US-5708024-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | NOVARTIS CORPORATION (US) | 1998-01-13 | — | — | US | disclosed |
| CN-1155274-A | New salts of 2-[(2,6-dichlorophenyl)amine] phenylacetoxyacetic acid with organic basic cations | CIBA GEIGY AG (CH) | 1997-07-23 | — | — | CN | disclosed |
| EP-0738706-A1 | Nitric esters of 2-(2,6-dihalophenylamino) phenylacetoxyacetic acid derivatives and their preparation process | PRODES, S.A. (ES) | 1996-10-23 | — | — | EP | disclosed |
| JP-S6363647-A | NOVEL 2-((2,6-DICHLOROPHENYL)AMINO)PHENYLACETOXYACETIC ACID DERIVATIVE | UJI SEIYAKU KK | 1988-03-22 | — | — | JP | disclosed |
| US-4548952-A | ANTINFLAMMATORY, ANALGESIC AGENTS | PRODES, S.A. (ES) | 1985-10-22 | — | — | US | disclosed |
| EP-0119932-A1 | New 2-((2,6-dichlorophenyl)amine)phenylacetoxyacetyl derivatives, the process for preparing the same and their use in therapeutics | PRODES S.A. (ES) | 1984-09-26 | — | — | EP | disclosed |